Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stein

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
BMC Cancer|September 26, 2018
Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patientsJulia Quidde, Yiqi Pan, Melanie Salm, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Dynamic structure of lipid-bound synaptobrevin suggests a nucleation-propagation mechanism for trans-SNARE complex formationJeffrey F Ellena, Binyong Liang, Maciej Wiktor, et al.
The Journal of Biological Chemistry|April 22, 2010
A coiled coil trigger site is essential for rapid binding of synaptobrevin to the SNARE acceptor complexKatrin Wiederhold, Tobias H Kloepper, Alexander M Walter, et al.
BMC Cancer|November 18, 2018
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancerStefan Kasper, Jens Kisro, Martin Fuchs, et al.
Plos One|May 17, 2016
Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®Tobias M Gorges, Alexander Stein, Julia Quidde, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancerStefan Peinert, Wilfried Grothe, Alexander Stein, et al.
BMC Palliative Care|March 2, 2016
Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot studyAnna Creutzfeldt, Anna Suling, Karin Oechsle, et al.
Oncology Research and Treatment|January 14, 2020
Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily WorkJudith Gebauer, Katja Baust, Edit Bardi, et al.
Current Cancer Drug Targets|June 30, 2020
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINELSven Nilsson, Alexander Stein, Christian Rolfo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Determinants of liposome fusion mediated by synaptic SNARE proteinsChristina G Schuette, Kiyotaka Hatsuzawa, Martin Margittai, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
BMC Cancer|September 26, 2018
Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patientsJulia Quidde, Yiqi Pan, Melanie Salm, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Dynamic structure of lipid-bound synaptobrevin suggests a nucleation-propagation mechanism for trans-SNARE complex formationJeffrey F Ellena, Binyong Liang, Maciej Wiktor, et al.
The Journal of Biological Chemistry|April 22, 2010
A coiled coil trigger site is essential for rapid binding of synaptobrevin to the SNARE acceptor complexKatrin Wiederhold, Tobias H Kloepper, Alexander M Walter, et al.
BMC Cancer|November 18, 2018
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancerStefan Kasper, Jens Kisro, Martin Fuchs, et al.
Plos One|May 17, 2016
Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®Tobias M Gorges, Alexander Stein, Julia Quidde, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancerStefan Peinert, Wilfried Grothe, Alexander Stein, et al.
BMC Palliative Care|March 2, 2016
Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot studyAnna Creutzfeldt, Anna Suling, Karin Oechsle, et al.
Oncology Research and Treatment|January 14, 2020
Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily WorkJudith Gebauer, Katja Baust, Edit Bardi, et al.
Current Cancer Drug Targets|June 30, 2020
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINELSven Nilsson, Alexander Stein, Christian Rolfo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Determinants of liposome fusion mediated by synaptic SNARE proteinsChristina G Schuette, Kiyotaka Hatsuzawa, Martin Margittai, et al.
Pageof 15